NO991772L - Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid - Google Patents

Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid

Info

Publication number
NO991772L
NO991772L NO991772A NO991772A NO991772L NO 991772 L NO991772 L NO 991772L NO 991772 A NO991772 A NO 991772A NO 991772 A NO991772 A NO 991772A NO 991772 L NO991772 L NO 991772L
Authority
NO
Norway
Prior art keywords
polypeptide
transition metal
hiv activity
metal salts
compound
Prior art date
Application number
NO991772A
Other languages
English (en)
Norwegian (no)
Other versions
NO991772D0 (no
Inventor
Akiyoshi Matsumoto
Michinori Waki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO991772D0 publication Critical patent/NO991772D0/no
Publication of NO991772L publication Critical patent/NO991772L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Insects & Arthropods (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991772A 1996-10-15 1999-04-14 Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid NO991772L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29121596 1996-10-15
PCT/JP1997/003711 WO1998016555A1 (fr) 1996-10-15 1997-10-15 Sels de metaux de transition d'un polypeptide et procede d'accroissement de l'activite anti-vih de ce polypeptide

Publications (2)

Publication Number Publication Date
NO991772D0 NO991772D0 (no) 1999-04-14
NO991772L true NO991772L (no) 1999-06-08

Family

ID=17765964

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991772A NO991772L (no) 1996-10-15 1999-04-14 Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid

Country Status (10)

Country Link
US (1) US6329498B1 (fr)
EP (1) EP1016672A4 (fr)
KR (1) KR20000049105A (fr)
CN (1) CN1233257A (fr)
AU (1) AU713591B2 (fr)
CA (1) CA2268011A1 (fr)
HU (1) HUP9904615A3 (fr)
NO (1) NO991772L (fr)
RU (1) RU2179981C2 (fr)
WO (1) WO1998016555A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CN100366633C (zh) * 2006-04-18 2008-02-06 河北师范大学 棕点湍蛙抗病毒多肽及其在制药中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2068327C (fr) * 1990-09-11 2002-01-01 Nobutaka Fujii Polypeptide et medicament anti-hiv prepare a partir de celui-ci
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗hiv剤
AU682405B2 (en) * 1993-10-14 1997-10-02 Seikagaku Corporation Polypeptide and anti-HIV agent prepared therefrom

Also Published As

Publication number Publication date
KR20000049105A (ko) 2000-07-25
AU713591B2 (en) 1999-12-09
EP1016672A1 (fr) 2000-07-05
EP1016672A4 (fr) 2001-04-11
CN1233257A (zh) 1999-10-27
RU2179981C2 (ru) 2002-02-27
CA2268011A1 (fr) 1998-04-23
WO1998016555A1 (fr) 1998-04-23
NO991772D0 (no) 1999-04-14
HUP9904615A3 (en) 2000-07-28
US6329498B1 (en) 2001-12-11
AU4572197A (en) 1998-05-11
HUP9904615A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
AU653972B2 (en) HIV protease inhibitors
CA2033392A1 (fr) Derives d'acide a-nor-steroide-3-carboxylique
CA2143208A1 (fr) Inhibiteurs de type sulonamide de l'aspartyl-protease du vih
AU697681B2 (en) Retroviral protease inhibiting compounds
EP0201289A3 (fr) Composés antiviraux
EP0423714A3 (en) Hair revitalizing agent
DK232989A (da) Antiviralt praeparat
AU1639888A (en) Novel oxetanocins
CA2068327A1 (fr) Polypeptide et medicament anti-hiv prepare a partir de celui-ci
CA2016656A1 (fr) Inhibiteurs d'enzyme
EP0394553A3 (fr) Utilisation des dérivés de l'acide pyridone carboxylique contenant du fluor pour fabriquer un médicament destiné au traitement des infection par le HIV
KR890009389A (ko) 바이러스를 억제시키는 방법
NO991772L (no) Overgangsmetallsalter av polypeptid samt fremgangsmÕte ved °king av anti-HIV-aktivitet av slikt polypeptid
IE781078L (en) Amino acids.
IE780279L (en) Imidazole derivatives
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
DE69625482D1 (de) Phosphinsäurederivate mit metallopeptidase-inhibitorischer wirkung
JPS543074A (en) Novel peptide derivative
EP0337643A3 (fr) Dérivés d'acide pénicillanique 6-acrylamino substitué, préparation et application
CA2022323A1 (fr) Excretion d'ions potassium par des derives de l'acide prostanoique
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
CA2166061A1 (fr) Nouvelles methodes pour preparer l'acide (s)-4-aminohepta-5,6-dienoique et des intermediaires
CA2155129A1 (fr) Combinaisons d'inhibiteurs retroviraux
DE69222438T2 (de) Aids-virus-infektion hemmende zusammensetzung
CA2176376A1 (fr) Utilisation de derives de 2-amino purine utilises dans le traitement et la prophylaxie des infections dues a l'herpesvirus 6 chez l'homme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application